U.S. Renewable Energy Stock News

This article walks through key numbers to help you judge whether Covista is priced attractively or already fully valued, so you can compare the stock against your own expectations. Covista recently closed at US$118.07, with returns of 4.3% over the last week, 0.1% over the past month, 13.0% year to date and 4.7% over the last year. Recent coverage around Covista has focused on its share price performance and how investors are reassessing the stock in light of broader sector moves. This...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see RPC, Inc...

Celebrations may be in order for Sterling Infrastructure, Inc. ( NASDAQ:STRL ) shareholders, with the analysts...

If you are wondering whether Arcus Biosciences is reasonably priced or getting ahead of itself, the current share price invites a closer look at what investors may actually be paying for. The stock last closed at US$26.06, with returns of 5.1% over the past 7 days, 13.5% over 30 days, 11.9% year to date, and 220.9% over the last year, which points to a stock that has already seen significant movement. Recent coverage around Arcus Biosciences has focused on its position in the biotech space...

Unsurprisingly, Seagate Technology Holdings plc's ( NASDAQ:STX ) stock price was strong on the back of its healthy...

Investors who take an interest in Option Care Health, Inc. ( NASDAQ:OPCH ) should definitely note that the Executive VP...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

As you might know, Solaris Energy Infrastructure, Inc. ( NYSE:SEI ) just kicked off its latest quarterly results with...

If you are wondering whether Upstart Holdings at around US$31.17 is priced for a comeback or still carrying too much risk, the starting point is to understand what the current market value really reflects. The stock has been volatile, with a 5.1% decline over the last 7 days, a 21.9% gain over the last 30 days, a 32.0% decline year to date, and a 39.4% decline over the last year. The 3-year return sits at 121.2%, and the 5-year return at a 65.1% decline. Recent coverage around Upstart often...

ARK Invest recently acquired over 3 million Intellia Therapeutics shares, worth more than US$43 million. The purchase reflects increased institutional interest in Intellia Therapeutics, which trades under ticker NasdaqGM:NTLA. This transaction follows earlier coverage that focused on Intellia's clinical programs, regulatory updates, and financial position. Intellia Therapeutics focuses on CRISPR/Cas9-based therapeutics, an area that many investors watch closely as gene editing moves from...

Soleno Therapeutics stock overview Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%. See our latest analysis for Soleno Therapeutics. That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...

Event overview and why it matters for Westamerica Bancorporation (WABC) Westamerica Bancorporation (WABC) has expanded its share repurchase authorization to 4,000,000 shares and lifted its quarterly dividend to $0.48, indicating a focus on returning cash to shareholders. See our latest analysis for Westamerica Bancorporation. At a share price of $54.75, Westamerica Bancorporation has a 30 day share price return of 5.63% and a year to date share price return of 14.47%, alongside a 3 year total...

Suncrete (NasdaqGM:RMIX) has appointed Charles Owens and Noreen Skelly as independent directors to its Board. Both Owens and Skelly have also joined the Audit Committee, with Skelly serving as Chair. The appointments expand the Board and Audit Committee with additional construction and banking sector expertise. Suncrete, trading at around $15.4, has seen its share price move 38.9% over the past 30 days and 35.1% year to date, with a 39.1% return over the past year and a 2.7% decline over...

Emerging discounting on core On Holding products at key retailers and outlets has raised fresh questions about the strength of the NYSE:ONON premium brand. Channel checks highlight margin pressure in the wholesale channel, challenging recent messaging around full price discipline and margin expansion. The news follows the return of the co founders as co CEOs and arrives as investors reassess growth and profitability expectations. On Holding, trading at $34.59 under ticker NYSE:ONON, is...

Investors may be wondering if First American Financial at around US$68 per share still offers value, or if most of the easy gains are already on the table. The stock is up 17.4% over the last 30 days and 12.0% year to date, with a 15.6% return over the past year and a 31.1% return over three years. These changes can influence how the market is pricing its risks and opportunities. These moves are playing out against a backdrop of ongoing interest in US insurance stocks and property related...

CNH Industrial (NYSE:CNH) is in active labor negotiations with nearly 300 UAW workers at its Racine, Wisconsin plant as their contract expires. The discussions follow a previous extended strike at the facility and there is currently no strike action in place. The talks are taking place while the company reports weak Q1 results, margin pressure, and historically low North American agricultural equipment demand. Management has reaffirmed its 2026 guidance, but labor uncertainty at Racine could...

Madrigal Pharmaceuticals (NasdaqGS:MDGL) has secured an exclusive worldwide license to ARO-PNPLA3, an RNAi therapy for MASH, from Arrowhead Pharmaceuticals. The program is in clinical development, with Phase 1 data indicating substantial liver fat reduction and a favorable safety profile in a genetically defined MASH population. The deal expands Madrigal's pipeline beyond Rezdiffra and adds a precision medicine angle to its MASH franchise. Madrigal Pharmaceuticals enters this agreement with...

This article examines whether Vestis is attractively priced or already fully valued and walks through key signals that can help frame the stock's current valuation. Vestis recently closed at US$9.27, with returns of 18.4% over 30 days and 40.9% year to date. Meanwhile, the 7 day return of 3.6% and 1 year return of 6.4% indicate that the stock has not moved in a straight line. Recent headlines around Vestis have focused on its position within the Commercial Services sector and how investors...

If you are wondering whether MYR Group at around US$468.54 is offering value after such a strong run, or if you are late to the story, this article focuses squarely on what the numbers say about the stock's price. The share price has moved sharply, with returns of 41.6% over the past week, 64.0% over the past month, 106.7% year to date and 206.4% over the past year, which has naturally sharpened interest in what is now priced in. Recent coverage has centered on MYR Group's role as a...

Morningstar (NasdaqGS:MORN) has launched the Europe Modern Market 50 Index, a hybrid benchmark tracking major public and high growth private companies in Europe. The index combines large listed equities with influential late stage, venture backed private firms to reflect their growing role in European equity markets. The product draws on Morningstar’s private markets data capabilities through its PitchBook subsidiary. For you as an investor, the launch highlights how Morningstar is leaning...

GPGI, the operating platform of Resolute Holdings Management (NYSE:RHLD), has acquired Husky. The deal adds another fee generating business to RHLD's platform and supports its earnings base. The acquisition is intended to support both organic expansion and further acquisitions for RHLD. Resolute Holdings Management, through its GPGI platform, focuses on building a recurring management fee base that can scale over time. The addition of Husky fits this model by broadening the pool of fee...

Apple Hospitality REIT’s Q1 2026 Earnings Snapshot Apple Hospitality REIT (APLE) opened 2026 with Q1 Funds From Operations of US$76.5 million and trailing 12 month net profit margins of 12.4%, while the stock trades around US$13.61. Over the past reported quarters, revenue has moved from US$333.0 million in Q4 2024 to US$327.7 million in Q1 2025 and US$326.4 million in Q4 2025, alongside basic EPS readings between US$0.12 and US$0.27 and trailing 12 month FFO in the US$359.2 million range...

Progressive (NYSE:PGR) is expanding its UpPayment program to offer larger down payment assistance for first-time homebuyers. The initiative aims to support hundreds of eligible applicants as part of a broader push to make homeownership more accessible. The program expansion is positioned within Progressive's wider homeownership and community engagement efforts. Progressive, trading at around $197.74, is drawing attention not for its share price moves but for this new push into direct...